Journey Medical Corp
DERM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001867066
No open-market purchases or sales by Journey Medical Corp insiders were filed in the last 90 days; 71 institutions reported holding it in 13F filings for Q2 2026, worth $75.2M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Journey Medical Corp changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 20 | 18 | −2 |
| Shares | 1.88M | 2.67M | +793.9K (+42.3%) |
| Value | $4.62M | $5.13M | +$510.9K (+11.1%) |
New holders (4)
Institutions that held Journey Medical Corp at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| B. Riley Securities, Inc. | 864,695 | $1.66M | 0.36% |
| Nantahala Capital Management, LLC | 225,996 | $433.9K | 0.04% |
| Allegiance Financial Group Advisory Services LLC | 10,000 | $19.2K | 0.02% |
| Bank of America Corp | 14 | $26 | 0.00% |
Sold out (6)
Institutions that held Journey Medical Corp at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Opaleye Management Inc. | 259,293 | $638.0K |
| Susquehanna International Group, LLP | 22,094 | $54.0K |
| Buckingham Strategic Partners | 10,000 | $25.0K |
| UBS Group AG | 1,444 | $4.00K |
| Essex Investment Management Co LLC | 1,400 | $3.00K |
| Royal Bank of Canada | 47 | $0 |